Pharmaceutical Industry Information Portal

HomeDiscovery and Development

Discovery and Development

Open Orphan signs a £7.3 million contract for influenza human challenge study

Open Orphan PLC said Wednesday that its hVIVO subsidiary has signed a 7.3 million pounds ($9.1 million) influenza human challenge study contract with an...

Startup RQ Biotechnology received $157 million from AstraZeneca for Covid antibodies

RQ Bio emerges from stealth mode announcing its launch as a new UK-based biotechnology company following the completion of a successful licensing deal with...

MicroGEM’s PCR test, which gives results in 27 minutes, received EUA approval from FDA

MicroGEM has been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the MicroGEM Sal6830 SARS-CoV-2 Saliva Test, which...

Yale, JDRF and NexImmune, $600,000 grant for diabetes research

NexImmune, Inc., Yale and JDRF have begun a two-year project to explore the use of NexImmune’s AIM nanoparticles in combination with an anti-CD3 mAb...

FDA lifts ban on LogicBio’s clinical trial on pediatric patients with methylmalonic acidemia

LogicBio Therapeutics, Inc., a clinical-stage company advancing a diversified pipeline of genetic medicines addressing rare disorders from infancy through adulthood, May 9th announced that...

AbbVie and Cerebras collaborate to accelerate artificial intelligence biopharmaceutical research

Cerebras Systems, the pioneer in high performance artificial intelligence (AI) computing, and AbbVie, a global biopharmaceutical company, announced a landmark achievement in AbbVie’s AI...
spot_img

Expert Articles

spot_img